PRODUCT LITERATURE

Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure

---

Diabetes is a risk factor for heart failure, and both conditions are increasing. Identifying treatments that
prevent both conditions will be clinically important. We previously reported that candesartan (an angiotensin receptor
blocker) reduces cardiovascular mortality and heart failure hospitalizations in heart failure patients (CHARM:
Candesartan in Heart Failure—Assessment of Reduction in Mortality and Morbidity Program).

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Canderin

Specific Detail Info

Circulation. 2005;112:48-53

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment